Monopar Therapeutics (MNPR) Insider Trading

Name: Monopar Therapeutics (MNPR) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 2, 2026): Cittadine Andrew (Chief Operating Officer): Exercise/Conversion of 4,384 shares.

Get alerted when insiders trade MNPR

Email address

Loading company data...

Beta

Loading company details...

Beta